undamentalytics Newsletter
Sign in

Quidelortho Corp revenue

Quidelortho Corp's revenue was $2.73bn in fiscal 2025, down 1.9% on the year before. Since fiscal 2020 ($1.66bn) it has grown at a compound 10.4% a year. Over the last twelve months it was $2.67bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Jan 20212021Jan 20222022Jan 20232023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,6621,6993,2662,9982,7832,7302,674
Growth on the year before—+2.2%+92.3%−8.2%−7.2%−1.9%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 28, 2025
Geography
Region Revenue Share YoY
Domestic Country $1.4B 52.6% ▼ 8.4%
Foreign Country $1.3B 47.4% ▲ 6.5%

From Quidelortho Corp's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Quidelortho Corp $2.67bn -2.5% -5.4%
Revvity $2.91bn 4.1% 0.9%
Insulet Corporation $3.05bn 29.4% 27.7%
Enovis Corp $2.30bn 4.9% 12.2%
Globus Medical Inc $3.14bn 19.7% 42.1%
Teleflex Inc $2.25bn 30.7% -8.0%

Compare with peers

Head to head: QDEL vs RVTYPODD vs QDELENOV vs QDELGMED vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Quidelortho Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quidelortho Corp.